BIIB - Wells Fargo downgrades Biogen to equal weight cites Skyclarys sales
2024-02-14 09:50:29 ET
More on Biogen
- Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade)
- Biogen Inc. (BIIB) Q4 2023 Earnings Call Transcript
- Biogen Inc. 2023 Q4 - Results - Earnings Call Presentation
- Biogen slips as outlook disappoints amid flat Leqembi sales
- Biogen misses top-line and bottom-line estimates; initiates FY24 outlook